HI
IDXX icon

HBK Investments’s Idexx Laboratories IDXX Stock Holding History

HBK Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,200
Closed -$726K – 650
2020
Q2 		$726K Buy
+2,200
New +$637K 0.01% 417
2020
Q1 		– Sell
-6,400
Closed -$1.67M – 253
2019
Q4 		$1.67M Buy
+6,400
New +$1.69M 0.02% 451

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HBK Investments's IDXX Position: Q4 2020 in Review

HBK Investments sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 3,716 shares — an estimated $1.66M sold.

HBK Investments first reported a position in IDXX in Q3 2014 and held it in 7 quarters. The position peaked at $3.42M in Q3 2017. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

  • HBK Investments reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
  • HBK Investments sold 3,716 Idexx Laboratories shares in Q4 2020, an estimated $1.66M.
  • HBK Investments first reported a position in Idexx Laboratories in Q3 2014 and held it in 7 quarters.
  • HBK Investments's Idexx Laboratories position peaked at $3.42M in Q3 2017.
  • 972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on HBK Investments's 13F filing for Q4 2020, filed 16 Feb 2021.